Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;27(1):303-305.
doi: 10.3201/eid2701.203027. Epub 2020 Oct 6.

Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy

Risk for SARS-CoV-2 Infection in Healthcare Workers, Turin, Italy

Andrea Calcagno et al. Emerg Infect Dis. 2021 Jan.

Abstract

We measured severe acute respiratory syndrome coronavirus 2 spike protein subunits S1/S2 antibodies by using capillary electrophoresis and a chemiluminescence immunoassay for 5,444 active healthcare workers in Italy. Seroprevalence was 6.9% and higher among participants having contact with patients. Seroconversion was not observed in 37/213 previously infected participants.

Keywords: COVID-19; Italy; SARS-CoV-2; Turin; age; coronavirus; coronavirus disease; healthcare workers; respiratory infections; risk; screening; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.

PubMed Disclaimer

Figures

Figure
Figure
Seroprevalence of severe acute respiratory syndrome coronavirus 2 antibodies in healthcare workers according to tasks of participants, Turin, Italy. Participants are grouped according to direct (black bars) or indirect/no contact (gray bars) with patients. The difference between these 2 groups (7.5% vs. 5.2%) is significant (p = 0.013 by χ2 test). The healthcare personnel category includes psychologists, nutritionists, welfare workers, religious assistants, physical therapists, and orthoptists.

Similar articles

Cited by

References

    1. Long Q-X, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26:845–8. 10.1038/s41591-020-0897-1 - DOI - PubMed
    1. Havers FP, Reed C, Lim T, Montgomery JM, Klena JD, Hall AJ, et al. Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23–May 12, 2020. JAMA Intern Med. 2020 Jul 21 [Epub ahead of print]. - PubMed
    1. Percivalle E, Cambiè G, Cassaniti I, Nepita EV, Maserati R, Ferrari A, et al. Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020. Euro Surveill. 2020;25:25. 10.2807/1560-7917.ES.2020.25.24.2001031 - DOI - PMC - PubMed
    1. Istituto Superiore di Sanità, Italian Ministry of Health. Integrated surveillance of COVID-19 in Italy [cited 2020 Sep 12]. https://www.epicentro.iss.it/coronavirus/bollettino/Infografica_19marzo%...
    1. Bonelli F, Sarasini A, Zierold C, Calleri M, Bonetti A, Vismara C, et al. Clinical and analytical performance of an automated serological test that identifies S1/S2-neutralizing IgG in COVID-19 patients semiquantitatively. J Clin Microbiol. 2020;58:e01224–20. 10.1128/JCM.01224-20 - DOI - PMC - PubMed